STOCK TITAN

[SCHEDULE 13D/A] PureCycle Technologies, Inc. Unit SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13D/A
Rhea-AI Filing Summary

Sylebra Capital and related entities have filed a Schedule 13D/A amendment regarding their significant stake in PureCycle Technologies. Key details include:

The reporting entities collectively own 34,934,774 shares, representing a 19.46% ownership stake. On June 16, 2025, they entered into subscription agreements to purchase 40,000 shares of Series B Convertible Preferred Stock in a private placement transaction.

  • The preferred shares are convertible to common stock with a 7% annual dividend rate
  • Conversion is subject to a 19.99% ownership cap
  • The transaction closed on June 20, 2025
  • The issuer must file a registration statement for resale of underlying common shares

The investment group includes Sylebra Capital LLC (Delaware), Sylebra Capital Ltd (Hong Kong), Sylebra Capital Management Ltd (Cayman Islands), and Daniel Patrick Gibson. The shares were acquired for investment purposes with the aim of increasing value. The filing indicates potential for future purchases or sales based on market conditions and other factors.

Sylebra Capital e le entità correlate hanno presentato un emendamento al Schedule 13D/A riguardante la loro significativa partecipazione in PureCycle Technologies. I dettagli principali includono:

Le entità segnalanti possiedono collettivamente 34.934.774 azioni, che rappresentano una quota di proprietà del 19,46%. Il 16 giugno 2025 hanno stipulato accordi di sottoscrizione per acquistare 40.000 azioni di azioni privilegiate convertibili di Serie B in un'operazione di collocamento privato.

  • Le azioni privilegiate sono convertibili in azioni ordinarie con un tasso di dividendo annuo del 7%
  • La conversione è soggetta a un limite di proprietà del 19,99%
  • L'operazione si è conclusa il 20 giugno 2025
  • L'emittente deve presentare una dichiarazione di registrazione per la rivendita delle azioni ordinarie sottostanti

Il gruppo di investimento comprende Sylebra Capital LLC (Delaware), Sylebra Capital Ltd (Hong Kong), Sylebra Capital Management Ltd (Isole Cayman) e Daniel Patrick Gibson. Le azioni sono state acquisite a scopo di investimento con l'obiettivo di aumentarne il valore. La comunicazione indica la possibilità di futuri acquisti o vendite in base alle condizioni di mercato e ad altri fattori.

Sylebra Capital y entidades relacionadas han presentado una enmienda al Schedule 13D/A respecto a su participación significativa en PureCycle Technologies. Los detalles clave incluyen:

Las entidades informantes poseen colectivamente 34.934.774 acciones, lo que representa una participación del 19,46%. El 16 de junio de 2025, suscribieron acuerdos para comprar 40.000 acciones de acciones preferentes convertibles Serie B en una transacción de colocación privada.

  • Las acciones preferentes son convertibles en acciones ordinarias con una tasa anual de dividendo del 7%
  • La conversión está sujeta a un límite de propiedad del 19,99%
  • La transacción se cerró el 20 de junio de 2025
  • El emisor debe presentar una declaración de registro para la reventa de las acciones ordinarias subyacentes

El grupo de inversión incluye a Sylebra Capital LLC (Delaware), Sylebra Capital Ltd (Hong Kong), Sylebra Capital Management Ltd (Islas Caimán) y Daniel Patrick Gibson. Las acciones fueron adquiridas con fines de inversión y con la intención de incrementar su valor. La presentación indica la posibilidad de futuras compras o ventas según las condiciones del mercado y otros factores.

Sylebra Capital 및 관련 법인들이 PureCycle Technologies에 대한 주요 지분과 관련하여 Schedule 13D/A 수정서를 제출했습니다. 주요 내용은 다음과 같습니다:

보고 기관들은 총 34,934,774주를 보유하고 있으며, 이는 19.46%의 지분율에 해당합니다. 2025년 6월 16일, 이들은 사모 거래를 통해 40,000주의 시리즈 B 전환 우선주를 매수하기 위한 구독 계약을 체결했습니다.

  • 우선주는 연 7% 배당률을 가진 보통주로 전환 가능합니다
  • 전환은 19.99% 소유 한도에 따릅니다
  • 거래는 2025년 6월 20일에 완료되었습니다
  • 발행사는 기초 보통주 재판매를 위한 등록 서류를 제출해야 합니다

투자 그룹에는 Sylebra Capital LLC(델라웨어), Sylebra Capital Ltd(홍콩), Sylebra Capital Management Ltd(케이맨 제도), 그리고 Daniel Patrick Gibson이 포함되어 있습니다. 주식은 투자 목적으로 취득되었으며 가치 증대를 목표로 합니다. 제출서류는 시장 상황 및 기타 요인에 따라 향후 매입 또는 매도 가능성을 시사합니다.

Sylebra Capital et les entités associées ont déposé un amendement au Schedule 13D/A concernant leur participation significative dans PureCycle Technologies. Les points clés sont les suivants :

Les entités déclarantes détiennent collectivement 34 934 774 actions, représentant une participation de 19,46%. Le 16 juin 2025, elles ont conclu des accords de souscription pour acheter 40 000 actions d'actions privilégiées convertibles de série B dans le cadre d'une transaction de placement privé.

  • Les actions privilégiées sont convertibles en actions ordinaires avec un taux de dividende annuel de 7%
  • La conversion est soumise à un plafond de détention de 19,99%
  • La transaction a été finalisée le 20 juin 2025
  • L'émetteur doit déposer une déclaration d'enregistrement pour la revente des actions ordinaires sous-jacentes

Le groupe d'investissement comprend Sylebra Capital LLC (Delaware), Sylebra Capital Ltd (Hong Kong), Sylebra Capital Management Ltd (Îles Caïmans) et Daniel Patrick Gibson. Les actions ont été acquises à des fins d'investissement dans le but d'accroître leur valeur. Le dépôt indique une possibilité d'achats ou de ventes futurs en fonction des conditions du marché et d'autres facteurs.

Sylebra Capital und verbundene Unternehmen haben eine Änderung des Schedule 13D/A bezüglich ihres bedeutenden Anteils an PureCycle Technologies eingereicht. Wichtige Details sind:

Die meldenden Einheiten besitzen zusammen 34.934.774 Aktien, was einem Eigentumsanteil von 19,46% entspricht. Am 16. Juni 2025 schlossen sie Zeichnungsvereinbarungen zum Kauf von 40.000 Aktien der Serie B wandelbaren Vorzugsaktien in einer Privatplatzierung ab.

  • Die Vorzugsaktien sind in Stammaktien wandelbar und bieten eine jährliche Dividendenrate von 7%
  • Die Wandlung ist an eine Eigentumsgrenze von 19,99% gebunden
  • Die Transaktion wurde am 20. Juni 2025 abgeschlossen
  • Der Emittent muss eine Registrierungsunterlage für den Wiederverkauf der zugrundeliegenden Stammaktien einreichen

Die Investorengruppe umfasst Sylebra Capital LLC (Delaware), Sylebra Capital Ltd (Hongkong), Sylebra Capital Management Ltd (Kaimaninseln) und Daniel Patrick Gibson. Die Aktien wurden zu Anlagezwecken erworben mit dem Ziel, den Wert zu steigern. Die Meldung deutet auf mögliche zukünftige Käufe oder Verkäufe je nach Marktbedingungen und weiteren Faktoren hin.

Positive
  • Sylebra Capital entities significantly increased ownership to 19.46% stake through Series B Convertible Preferred Stock purchase
  • Major investment of 40,000 shares of Series B Convertible Preferred Stock demonstrates institutional confidence in company
  • Series B Preferred Stock terms include favorable 7% cumulative dividend rate and change of control protection
Negative
  • Significant ownership concentration risk with single investor group holding nearly 20% of shares
  • Potential future dilution from conversion of Series B Preferred Stock into common shares
  • New preferred stock issuance adds complexity to capital structure and increases dividend obligations

Sylebra Capital e le entità correlate hanno presentato un emendamento al Schedule 13D/A riguardante la loro significativa partecipazione in PureCycle Technologies. I dettagli principali includono:

Le entità segnalanti possiedono collettivamente 34.934.774 azioni, che rappresentano una quota di proprietà del 19,46%. Il 16 giugno 2025 hanno stipulato accordi di sottoscrizione per acquistare 40.000 azioni di azioni privilegiate convertibili di Serie B in un'operazione di collocamento privato.

  • Le azioni privilegiate sono convertibili in azioni ordinarie con un tasso di dividendo annuo del 7%
  • La conversione è soggetta a un limite di proprietà del 19,99%
  • L'operazione si è conclusa il 20 giugno 2025
  • L'emittente deve presentare una dichiarazione di registrazione per la rivendita delle azioni ordinarie sottostanti

Il gruppo di investimento comprende Sylebra Capital LLC (Delaware), Sylebra Capital Ltd (Hong Kong), Sylebra Capital Management Ltd (Isole Cayman) e Daniel Patrick Gibson. Le azioni sono state acquisite a scopo di investimento con l'obiettivo di aumentarne il valore. La comunicazione indica la possibilità di futuri acquisti o vendite in base alle condizioni di mercato e ad altri fattori.

Sylebra Capital y entidades relacionadas han presentado una enmienda al Schedule 13D/A respecto a su participación significativa en PureCycle Technologies. Los detalles clave incluyen:

Las entidades informantes poseen colectivamente 34.934.774 acciones, lo que representa una participación del 19,46%. El 16 de junio de 2025, suscribieron acuerdos para comprar 40.000 acciones de acciones preferentes convertibles Serie B en una transacción de colocación privada.

  • Las acciones preferentes son convertibles en acciones ordinarias con una tasa anual de dividendo del 7%
  • La conversión está sujeta a un límite de propiedad del 19,99%
  • La transacción se cerró el 20 de junio de 2025
  • El emisor debe presentar una declaración de registro para la reventa de las acciones ordinarias subyacentes

El grupo de inversión incluye a Sylebra Capital LLC (Delaware), Sylebra Capital Ltd (Hong Kong), Sylebra Capital Management Ltd (Islas Caimán) y Daniel Patrick Gibson. Las acciones fueron adquiridas con fines de inversión y con la intención de incrementar su valor. La presentación indica la posibilidad de futuras compras o ventas según las condiciones del mercado y otros factores.

Sylebra Capital 및 관련 법인들이 PureCycle Technologies에 대한 주요 지분과 관련하여 Schedule 13D/A 수정서를 제출했습니다. 주요 내용은 다음과 같습니다:

보고 기관들은 총 34,934,774주를 보유하고 있으며, 이는 19.46%의 지분율에 해당합니다. 2025년 6월 16일, 이들은 사모 거래를 통해 40,000주의 시리즈 B 전환 우선주를 매수하기 위한 구독 계약을 체결했습니다.

  • 우선주는 연 7% 배당률을 가진 보통주로 전환 가능합니다
  • 전환은 19.99% 소유 한도에 따릅니다
  • 거래는 2025년 6월 20일에 완료되었습니다
  • 발행사는 기초 보통주 재판매를 위한 등록 서류를 제출해야 합니다

투자 그룹에는 Sylebra Capital LLC(델라웨어), Sylebra Capital Ltd(홍콩), Sylebra Capital Management Ltd(케이맨 제도), 그리고 Daniel Patrick Gibson이 포함되어 있습니다. 주식은 투자 목적으로 취득되었으며 가치 증대를 목표로 합니다. 제출서류는 시장 상황 및 기타 요인에 따라 향후 매입 또는 매도 가능성을 시사합니다.

Sylebra Capital et les entités associées ont déposé un amendement au Schedule 13D/A concernant leur participation significative dans PureCycle Technologies. Les points clés sont les suivants :

Les entités déclarantes détiennent collectivement 34 934 774 actions, représentant une participation de 19,46%. Le 16 juin 2025, elles ont conclu des accords de souscription pour acheter 40 000 actions d'actions privilégiées convertibles de série B dans le cadre d'une transaction de placement privé.

  • Les actions privilégiées sont convertibles en actions ordinaires avec un taux de dividende annuel de 7%
  • La conversion est soumise à un plafond de détention de 19,99%
  • La transaction a été finalisée le 20 juin 2025
  • L'émetteur doit déposer une déclaration d'enregistrement pour la revente des actions ordinaires sous-jacentes

Le groupe d'investissement comprend Sylebra Capital LLC (Delaware), Sylebra Capital Ltd (Hong Kong), Sylebra Capital Management Ltd (Îles Caïmans) et Daniel Patrick Gibson. Les actions ont été acquises à des fins d'investissement dans le but d'accroître leur valeur. Le dépôt indique une possibilité d'achats ou de ventes futurs en fonction des conditions du marché et d'autres facteurs.

Sylebra Capital und verbundene Unternehmen haben eine Änderung des Schedule 13D/A bezüglich ihres bedeutenden Anteils an PureCycle Technologies eingereicht. Wichtige Details sind:

Die meldenden Einheiten besitzen zusammen 34.934.774 Aktien, was einem Eigentumsanteil von 19,46% entspricht. Am 16. Juni 2025 schlossen sie Zeichnungsvereinbarungen zum Kauf von 40.000 Aktien der Serie B wandelbaren Vorzugsaktien in einer Privatplatzierung ab.

  • Die Vorzugsaktien sind in Stammaktien wandelbar und bieten eine jährliche Dividendenrate von 7%
  • Die Wandlung ist an eine Eigentumsgrenze von 19,99% gebunden
  • Die Transaktion wurde am 20. Juni 2025 abgeschlossen
  • Der Emittent muss eine Registrierungsunterlage für den Wiederverkauf der zugrundeliegenden Stammaktien einreichen

Die Investorengruppe umfasst Sylebra Capital LLC (Delaware), Sylebra Capital Ltd (Hongkong), Sylebra Capital Management Ltd (Kaimaninseln) und Daniel Patrick Gibson. Die Aktien wurden zu Anlagezwecken erworben mit dem Ziel, den Wert zu steigern. Die Meldung deutet auf mögliche zukünftige Käufe oder Verkäufe je nach Marktbedingungen und weiteren Faktoren hin.






If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D


SYLEBRA CAPITAL LLC
Signature:/s/ Matthew Whitehead
Name/Title:Matthew Whitehead, Authorized Signatory
Date:06/24/2025
Sylebra Capital Ltd
Signature:/s/ Matthew Whitehead
Name/Title:Matthew Whitehead, Authorized Signatory
Date:06/24/2025
Sylebra Capital Management, Ltd
Signature:/s/ Matthew Whitehead
Name/Title:Matthew Whitehead, Authorized Signatory
Date:06/24/2025
Gibson Daniel Patrick
Signature:/s/ Daniel Patrick Gibson
Name/Title:Daniel Patrick Gibson, Individual
Date:06/24/2025

FAQ

What is Sylebra Capital's ownership stake in PCTTU as of June 2025?

According to the Schedule 13D/A filing, Sylebra Capital and its affiliated entities beneficially own 34,077,574 shares representing approximately 18.98% of PureCycle Technologies (PCTTU). Including Daniel Gibson's personal holdings, the total ownership reaches 34,934,774 shares or 19.46% of the company.

What major transaction did PCTTU complete with Sylebra Capital in June 2025?

On June 20, 2025, PCTTU completed a private placement transaction with Sylebra Capital's affiliated entities, selling 40,000 shares of Series B Convertible Preferred Stock. These shares are convertible to common stock and accrue dividends at 7% per annum, payable in kind or cash at PCTTU's option.

What are the key terms of PCTTU's Series B Convertible Preferred Stock issued to Sylebra Capital?

The Series B Convertible Preferred Stock has several key terms: 1) 7% annual cumulative dividend rate, 2) convertible to common stock subject to a 19.99% ownership cap, 3) liquidation preference equal to the greater of accrued value or conversion value, 4) redemption rights in case of change in control, and 5) issuer conversion rights after 3 years if certain trading conditions are met.

Who are the reporting persons in PCTTU's Schedule 13D/A filing?

The reporting persons are: 1) Sylebra Capital LLC (Delaware-based), 2) Sylebra Capital Ltd (Hong Kong-based), 3) Sylebra Capital Management, Ltd (Cayman Islands-based), and 4) Daniel Patrick Gibson (individual investor). These entities collectively manage and control the PCTTU investment position.

What is PCTTU required to do regarding the registration of shares from this transaction?

According to the filing, PCTTU is required to prepare and file a registration statement with the SEC under the Securities Act of 1933 to cover the resale of common stock shares underlying the Series B Convertible Preferred Stock issued in this transaction.
Purecycle Technologies Inc

NASDAQ:PCTTU

PCTTU Rankings

PCTTU Latest News

PCTTU Latest SEC Filings

PCTTU Stock Data

7.50M
0.14%
Pollution & Treatment Controls
Plastic Materials, Synth Resins & Nonvulcan Elastomers
Link
United States
ORLANDO